期刊文献+

佩尔地平注射剂治疗高血压急症的疗效 被引量:4

CLINICAL STUDIES ON NICARDIPINE INJECTION IN TREATMENT OF HYPERTENSIVE CRISIS
下载PDF
导出
摘要 目的:研究静脉注射佩尔地平治疗高血压急症的有效性及安全性。方法:实验组20例,用佩尔地平0.5~2.5μg/(kg·min)静点;对照组19例,用硝普钠0.5~3.0μg/(kg·min)静点。结果:实验组用药后5~10min开始有显著的降压作用,60min后疗效更显著,血压由(25.4±3.9)/(15.7±1.3)kPa降至(18.0±3.2)/(11.5±1.5)kPa,静点速度以1.0~2.0μg/(kg·min)为宜;患者自觉症状改善明显,副作用轻微。对照组用药后10min血压也开始下降,30~60min血压明显下降。两组药物的降压作用均明显。结论:佩尔地平静点是治疗高血压急症迅速、有效。 OBJECTIVE:The effectiveness and safety of nicardipine injection in treatment of hypertensive crisis were studied by the authors in comparison with sodium nitroprusside(SNP).METHODS:Twenty patients in the active group were treated with nicardipine by infusion in a speed of 0.5~2.5 μg/(kg·min)while another nineteen patients in the control group were treated with SNP by infusion in a speed of 0.5~3.0 μg/(kg·min).RESULTS:The blood pressure (BP)in patients of the active group began to drop significantly after 5~10 min of dosing and obvious effect was observed after 60 mins,the BP decreased from(25.4±3.9)/(15.7±1.3)kPa to (18.0±3.2)/(11.5±1.5)kPa and it was found that the infusion speed maintained at 1.0~2.0 μg/(kg·min)seems to be adequate,for the symptoms of the patients were relived without obvious side effects.The BP in patients of the control group were also decreased significantly after 30~60 min of dosing.CONCLUSION:Nicardipine injection is an effective and safe agent for rapid relief of hypertensive crisis.
出处 《中国新药杂志》 CAS CSCD 1998年第5期374-376,共3页 Chinese Journal of New Drugs
关键词 高血压 急症 佩尔地平 硝普钠 治疗 Hypertensive emergency Nicardipine Nitroprusside
  • 相关文献

参考文献1

  • 1陈国伟,(美)郑宗锷.现代心脏内科学[M]湖南科学技术出版社,1994.

同被引文献17

  • 1杨孜.早发型重度先兆子痫——产科医师面临的挑战[J].中国妇产科临床杂志,2003,4(2):83-84. 被引量:125
  • 2杨孜,李蓉,石凌懿,王丽娜,叶蓉华,王荣,黄萍.早发型重度先兆子痫的临床界定及保守治疗探讨[J].中华妇产科杂志,2005,40(5):302-305. 被引量:333
  • 3张艳华 顾虎.佩尔地平控制术后高血压的临床观察.临床麻醉学杂志,1999,15(3):183-183.
  • 4Jannet D, Abankwa A, Guyard B, et al. Nicardiping versus salbutamol in the treatment of premature labor: a prospoctive randomized study [ J ]. Eur J Obstet and Gynecol, 1997,73 ( 5 ) : 111.
  • 5Jannet D, Carbonne B, Sebban E, et al. Nicardiping versus motoproloi in the treatment of hypertension during pregnancy:a randomized comparative trial[ J ]. Obstet Gyneeol, 1994,84 : 3354.
  • 6Branch DW, Andros R, Digre KB, et al. The association of antiphospholipid antibodies with severe preeelampsia [ J ]. Obstet Gynecol, 1989,73 (7) :541 - 545.
  • 7Song J, Zhang S, Qiao Y, et al. Predicting pregnancy- induced hypertension with dynamic hemodynamics [ J ]. Eur J Obstet Gynecol Reprod Biol, 2004, 117(2): 162-168.
  • 8The Eclampsia Trial Collaboratlve Group. Which anticonvulsant for women with eclampisa? Evidence from the Collaborative Eclampsia Trial[ J ]. Lancet, 1995,345 (9) : 1455 - 1463.
  • 9Krishnaiah YSR, Satyanarayana V, Bhaskar P. Formulation and invivo evaluation of membrane - moderated transdermal therapeutic systems of nicardipine hydrochloride using earvone as a penetration enhancer[J]. Drug Delivery, 2003, 10 (2): 101 -109.
  • 10Alborch E, Salom JB, Perales A J, et al. Comparison of the anticonstrictor action of dihyclropyridines and Mg^2+ in isolated human cerebral arteries [ J ]. Enr J Pharmacal, 1992,229 ( 1 ) : 83 - 89.

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部